SINGAPORE - The number of heat exhaustion injuries suffered by Singapore Armed Forces (SAF) servicemen has fallen from seven in 2021 to two in 2023, with no cases of heat stroke among these incidents.

Each year, the Singapore Armed Forces’ Inspector-General's Office (IGO) conducts 40 to 50 physical audits and reviews of safety standards and practices involving SAF formations and units.

Maggie O’Neill is a health writer and reporter based in New York who specializes in covering medical research and emerging wellness trends, with a focus on cancer and addiction. Prior to her ...

The Food and Drug Administration (FDA) recently removed Eli Lily's weight-loss drug from its shortage list, which some industry officials and medical experts argue will complicate access for some ...

Ideal Candidates for Tirzepatide Weight Loss 1. Adults with Obesity or Overweight with Weight-related Conditions The primary candidates for tirzepatide weight loss are adults who are classified as ...

The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness, as well as changing how the body processess food. (In other countries, tirzepatide is also ...

Four days after a compounding industry group filed a lawsuit against the FDA for removing Eli Lilly’s tirzepatide products from its shortage list, the U.S. regulator is taking a second look at ...

In a reversal, the Food and Drug Administration (FDA) said it will allow some compounding pharmacies to temporarily make their own versions of tirzepatide, the active ingredient in Eli Lilly’s ...

The U.S. Food and Drug Administration (FDA) is considering removing the tirzepatide medications Mounjaro (for diabetes) and Zepbound (for obesity) from its drug shortage list. If that happens ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug. HealthDay News — Pharmacists may continue ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a ...